Big Pharma and Biotech Rankings on Core Metrics

Big Pharma and Biotech Rankings on Core Metrics

Independent investment research firm Morningstar has published its latest Healthcare Observer, “Strong Pipelines Support Big Biotech and Big Pharma Moats and Attractive Valuations.” In the report, Morningstar equity analysts rank the large-cap drug companies on three...

Pin It on Pinterest